Skip to main content
Clinical Trials/ACTRN12620000641998
ACTRN12620000641998
Completed
未知

Ventricular Arrhythmias in Implantable Cardioverter Defibrillator Patients During the COVID-19 Pandemic

The University of Adelaide0 sites5,963 target enrollmentJune 1, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
The University of Adelaide
Enrollment
5963
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2020
End Date
June 5, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All patients with an implantable cardioverter defibrillator (ICD) in situ (inclusive of a standard ICD, a cardiac resynchronisation therapy defibrillator, or a subcutaneous ICD), who received remote monitoring of their ICD via the PaceMate remote monitoring service, during the first 100 days post the index confirmed COVID\-19 case in USA.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials